Wednesday, February 5, 2025 2/5/2025

PCB-mediated dysbiosis of the gut microbiome: A missing link in PCB-mediated neurodevelopmental disorders?

Award Number: R01ES031098
ORGANIZATION: NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

PROJECT SUMMARY/ABSTRACT Exposure of the developing brain to polychlorinated biphenyls (PCBs) and disruption of the gut microbiome have independently been implicated in the etiology of neurodevelopmental disorders (NDDs). Both phenomena likely interact by two mechanisms to cause adverse neurodevelopmental outcomes: PCB-mediated changes in the gut microbiome (1) alter the profile of neuroactive microbial metabolites distributed to the developing brain and (2) affect PCB disposition in the developing brain by modifying host and microbial PCB metabolism. A mechanistic understanding of these interactions is required to address the critical need for interventional strategies that effec- tively reduce the impact of PCB-induced NDDs on individuals, families, and society. The long-term goal is to de- termine the role of the gut microbiome–liver–brain axis in modulating susceptibility to PCB effects on the develop- ing brain, with the objective of characterizing how dose-dependent interactions between maternal exposure to an environmentally relevant PCB mixture and the gut microbiome influence neurotoxic outcomes in conventional (CV) vs. germ-free (GF) juvenile mice. We will test the central hypothesis that dysbiosis of the gut microbiome as- sociated with developmental exposure to varying doses of PCBs contributes to adverse neurodevelopmental out- comes later in life. This hypothesis is based on preliminary studies showing that: (1) PCB exposure causes dysbiosis of the gut microbiome; (2) PCBs and their metabolites are present in the rodent brain; (3) the expression of PCB-metabolizing enzymes differs between CV vs. GF mice; (4) PCB disposition differs between CV and GF mice; and (5) PCBs are developmental neurotoxicants in mice. Guided by these preliminary data, the novel hy- pothesis will be tested by (a) characterizing gut microbiome composition and function and neuroactive microbial metabolites; (b) determining how differences in host vs. microbial biotransformation affect disposition of PCBs and their metabolites; and (c) examining neuroinflammation, oxidative stress, synaptic connectivity, and behavior in dams and fetuses/pups derived from (i) CV vs.GF dams exposed to PCBs in the diet and (ii) GF dams who re- ceived a fecal transplant from PCB-exposed or vehicle control CV dams. The proposed research is innovative because it uses a systems biology approach in a state-of-the-art mouse model to assess the role of the gut mi- crobiome–liver–brain axis in modulating neurotoxic outcomes following exposure to an environmental PCB mix- ture. The anticipated outcome of these studies is a new research paradigm demonstrating that developmental exposures to PCBs mediate (1) longitudinal changes in gut microbiome composition and function and (2) alter PCB disposition in the developing brain that influence neurodevelopmental outcomes later in life. This outcome will have a significant impact on public health by informing future studies of cellular mechanisms of the devel- opmental origin of PCB neurotoxicity and, ultimately, provide critical insights regarding the plausibility of micro- biome-based approaches to diagnose and treat NDDs induced by exposure to neurotoxicants.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $619,202 )
2024	2024	THE UNIVERSITY OF IOWA	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Environmental Health	000	5	11/8/2023	NON-COMPETING CONTINUATION	$619,202
														Subtotal = $619,202

Issue Date FY: 2023 ( Subtotal = $619,202 )
2023	2023	UNIVERSITY OF IOWA, THE	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Environmental Health	000	4	11/21/2022	NON-COMPETING CONTINUATION	$619,202
														Subtotal = $619,202

Issue Date FY: 2022 ( Subtotal = $620,458 )
2022	2022	UNIVERSITY OF IOWA, THE	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Environmental Health	000	3	11/24/2021	NON-COMPETING CONTINUATION	$620,458
														Subtotal = $620,458

Issue Date FY: 2021 ( Subtotal = $621,086 )
2021	2021	UNIVERSITY OF IOWA, THE	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Environmental Health	000	2	11/17/2020	NON-COMPETING CONTINUATION	$621,086
														Subtotal = $621,086

Issue Date FY: 2020 ( Subtotal = $644,712 )
2020	2020	UNIVERSITY OF IOWA, THE	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Environmental Health	000	1	1/31/2020	NEW	$644,712
														Subtotal = $644,712

Grand Total All Awards = $3,124,660

Top

All Categories

About

Search

Reports

Data Submission

Award Information

PCB-mediated dysbiosis of the gut microbiome: A missing link in PCB-mediated neurodevelopmental disorders?

Award Number: R01ES031098

ORGANIZATION: NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer